Ftse Mib
33.695,41
-0,35%
DAX
18.395,66
-0,15%
S&P 500
5.472,41
0,24%
NASDAQ
17.508,86
0,87%
Bitcoin
68.891,47
1,61%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. USOTC TetraLogic Pharmaceuticals Corporation (CE) (TLOG) TetraLogic Pharmaceuticals Corporation (CE) (TLOG) Notizie

TLOG

TetraLogic Pharmaceuticals (CE) (TLOG)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:TLOG
DataOraFonteTitoloSimboloCompagnia
16/02/202112:30Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
27/06/201822:26Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
04/08/201721:20Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
03/11/201622:29Edgar (US Regulatory)Quarterly Report (10-q)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
03/11/201622:29Edgar (US Regulatory)Current Report Filing (8-k)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
03/11/201622:27Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
03/11/201618:13Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
03/11/201618:11Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
02/11/201621:30GlobeNewswire Inc.TetraLogic Announces Agreements to Sell SMAC mimetic and HDAC inhibitor assets to Medivir and to Restructure its Convertible ...USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
28/04/201612:21Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
16/03/201622:19Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
10/02/201620:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
06/01/201622:11GlobeNewswire Inc.TetraLogic Pharmaceuticals Announces Data on Lead Clinical ProgramsUSOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
09/11/201513:00GlobeNewswire Inc.TetraLogic Pharmaceuticals Announces Clinical Data on Birinapant to be Presented at the 57th Annual American Society of Hemat...USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
04/11/201522:01GlobeNewswire Inc.TetraLogic Reports Third Quarter Financial Results and Provides Clinical Programs UpdateUSOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
02/11/201513:00GlobeNewswire Inc.TetraLogic Announces the Opening of an IND for SHAPE Gel in Alopecia AreataUSOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
25/08/201512:02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
06/05/201518:52GlobeNewswire Inc.TetraLogic Announces Termination of Public OfferingUSOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
06/05/201516:14GlobeNewswire Inc.TetraLogic Announces Temporary Halt of Chronic Hepatitis B TrialUSOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
01/05/201514:56GlobeNewswire Inc.TetraLogic Announces Pricing of $25 Million Public OfferingUSOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
30/04/201522:01GlobeNewswire Inc.TetraLogic Announces Public Offering of Common StockUSOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
21/04/201514:00GlobeNewswire Inc.TetraLogic Announces Publication of Two Papers Describing Birinapant's Preclinical Activity in Chronic Hepatitis BUSOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
20/04/201514:00GlobeNewswire Inc.TetraLogic and Merck to Collaborate on the Evaluation of Birinapant in Combination With KEYTRUDA(R) (pembrolizumab) in Solid ...USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
09/04/201516:11GlobeNewswire Inc.TetraLogic to Present at the 14th Annual Needham Healthcare ConferenceUSOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
30/03/201520:50Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
26/02/201522:10GlobeNewswire Inc.TetraLogic Reports 2014 Financial Results and Provides Clinical Programs UpdateUSOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
26/02/201517:48Edgar (US Regulatory)Annual Report (10-k)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
17/02/201521:33Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
16/01/201512:01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
02/01/201518:57Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)USOTC:TLOGTetraLogic Pharmaceuticals Corporation (CE)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:TLOG

La tua Cronologia

BIT
S27025
Societe Generale Effekten
BIT
S27455
Societe Generale Effekten
BIT
P21HQ0
NLBNPIT21HQ0 20241218 42...
BIT
P128H9
BNP PARIBAS ISSUANCE
BIT
DTH
Defense Tech Holding Soc...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network